• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过调节 NEK7 抑制 NLRP3 炎性小体的激活。

Inhibition of NLRP3 inflammasome activation by A20 through modulation of NEK7.

机构信息

Department of Radiotherapy, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, Sichuan University, Chengdu 610041, China.

State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.

出版信息

Proc Natl Acad Sci U S A. 2024 Jun 18;121(25):e2316551121. doi: 10.1073/pnas.2316551121. Epub 2024 Jun 12.

DOI:10.1073/pnas.2316551121
PMID:38865260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11194493/
Abstract

The NLRP3 inflammasome, a pivotal component of innate immunity, has been implicated in various inflammatory disorders. The ubiquitin-editing enzyme A20 is well known to regulate inflammation and maintain homeostasis. However, the precise molecular mechanisms by which A20 modulates the NLRP3 inflammasome remain poorly understood. Here, our study revealed that macrophages deficient in A20 exhibit increased protein abundance and elevated mRNA level of NIMA-related kinase 7 (NEK7). Importantly, A20 directly binds with NEK7, mediating its K48-linked ubiquitination, thereby targeting NEK7 for proteasomal degradation. Our results demonstrate that A20 enhances the ubiquitination of NEK7 at K189 and K293 ubiquitinated sites, with K189 playing a crucial role in the binding of NEK7 to A20, albeit not significantly influencing the interaction between NEK7 and NLRP3. Furthermore, A20 disrupts the association of NEK7 with the NLRP3 complex, potentially through the OTU domain and/or synergistic effect of ZnF4 and ZnF7 motifs. Significantly, NEK7 deletion markedly attenuates the activation of the NLRP3 inflammasome in A20-deficient conditions, both in vitro and in vivo. This study uncovers a mechanism by which A20 inhibits the NLRP3 inflammasome.

摘要

NLRP3 炎性小体是先天免疫的关键组成部分,与各种炎症性疾病有关。泛素修饰酶 A20 是众所周知的调节炎症和维持体内平衡的酶。然而,A20 调节 NLRP3 炎性小体的确切分子机制仍知之甚少。在这里,我们的研究表明,缺乏 A20 的巨噬细胞表现出 NIMA 相关激酶 7(NEK7)的蛋白丰度增加和 mRNA 水平升高。重要的是,A20 直接与 NEK7 结合,介导其 K48 连接的泛素化,从而将 NEK7 靶向蛋白酶体降解。我们的结果表明,A20 增强了 NEK7 在 K189 和 K293 泛素化位点的泛素化,K189 在 NEK7 与 A20 的结合中起着关键作用,尽管它对 NEK7 与 NLRP3 的相互作用没有显著影响。此外,A20 破坏了 NEK7 与 NLRP3 复合物的关联,可能是通过 OTU 结构域和/或 ZnF4 和 ZnF7 结构域的协同作用。重要的是,NEK7 的缺失显著减弱了 A20 缺陷条件下 NLRP3 炎性小体的激活,无论是在体外还是体内。这项研究揭示了 A20 抑制 NLRP3 炎性小体的一种机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/11194493/44dfef33376f/pnas.2316551121fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/11194493/4940085650e9/pnas.2316551121fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/11194493/11760a71ef49/pnas.2316551121fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/11194493/434061247fec/pnas.2316551121fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/11194493/95a0075877f5/pnas.2316551121fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/11194493/da7d159502d0/pnas.2316551121fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/11194493/87fdfb9127c6/pnas.2316551121fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/11194493/44dfef33376f/pnas.2316551121fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/11194493/4940085650e9/pnas.2316551121fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/11194493/11760a71ef49/pnas.2316551121fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/11194493/434061247fec/pnas.2316551121fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/11194493/95a0075877f5/pnas.2316551121fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/11194493/da7d159502d0/pnas.2316551121fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/11194493/87fdfb9127c6/pnas.2316551121fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/11194493/44dfef33376f/pnas.2316551121fig07.jpg

相似文献

1
Inhibition of NLRP3 inflammasome activation by A20 through modulation of NEK7.通过调节 NEK7 抑制 NLRP3 炎性小体的激活。
Proc Natl Acad Sci U S A. 2024 Jun 18;121(25):e2316551121. doi: 10.1073/pnas.2316551121. Epub 2024 Jun 12.
2
A20 attenuates oxidized self-DNA-mediated inflammation in acute kidney injury.A20减轻急性肾损伤中氧化型自身DNA介导的炎症反应。
Signal Transduct Target Ther. 2025 Apr 25;10(1):154. doi: 10.1038/s41392-025-02194-y.
3
PLK4 deubiquitination by Spata2-CYLD suppresses NEK7-mediated NLRP3 inflammasome activation at the centrosome.Spata2-CYLD 通过去泛素化 PLK4 抑制中心体处 NEK7 介导的 NLRP3 炎性小体激活。
EMBO J. 2020 Jan 15;39(2):e102201. doi: 10.15252/embj.2019102201. Epub 2019 Nov 25.
4
NLRP3 phosphorylation in its LRR domain critically regulates inflammasome assembly.NLRP3 在其 LRR 结构域中的磷酸化对于炎症小体的组装至关重要。
Nat Commun. 2021 Oct 6;12(1):5862. doi: 10.1038/s41467-021-26142-w.
5
NIMA-related kinase 7 amplifies NLRP3 inflammasome pro-inflammatory signaling in microglia/macrophages and mice models of spinal cord injury.NIMA 相关激酶 7 在小胶质细胞/巨噬细胞和脊髓损伤小鼠模型中放大 NLRP3 炎性体炎症信号。
Exp Cell Res. 2021 Jan 15;398(2):112418. doi: 10.1016/j.yexcr.2020.112418. Epub 2020 Dec 9.
6
NEK7 mediated assembly and activation of NLRP3 inflammasome downstream of potassium efflux in ventilator-induced lung injury.NEK7 介导钾离子外流后呼吸机诱导肺损伤中 NLRP3 炎性小体的组装和激活。
Biochem Pharmacol. 2020 Jul;177:113998. doi: 10.1016/j.bcp.2020.113998. Epub 2020 Apr 27.
7
Inhibition of METTL3 Alleviates NLRP3 Inflammasome Activation via Increasing Ubiquitination of NEK7.抑制 METTL3 通过增加 NEK7 的泛素化来减轻 NLRP3 炎性小体的激活。
Adv Sci (Weinh). 2024 Jul;11(26):e2308786. doi: 10.1002/advs.202308786. Epub 2024 May 2.
8
NEK7 phosphorylation amplifies NLRP3 inflammasome activation downstream of potassium efflux and gasdermin D.NEK7磷酸化在钾离子外流和gasdermin D下游增强NLRP3炎性小体的激活。
Sci Immunol. 2025 Jan 3;10(103):eadl2993. doi: 10.1126/sciimmunol.adl2993.
9
Anemoside B4 targets NEK7 to inhibit NLRP3 inflammasome activation and alleviate MSU-induced acute gouty arthritis by modulating the NF-κB signaling pathway.芍药苷B4通过调节NF-κB信号通路靶向NEK7以抑制NLRP3炎性小体激活并减轻MSU诱导的急性痛风性关节炎。
Phytomedicine. 2025 Mar;138:156407. doi: 10.1016/j.phymed.2025.156407. Epub 2025 Jan 17.
10
A Single Amino Acid Residue Defines the Difference in NLRP3 Inflammasome Activation between NEK7 and NEK6.单一氨基酸残基定义了 NEK7 和 NEK6 之间 NLRP3 炎性小体激活的差异。
J Immunol. 2022 Apr 15;208(8):2029-2036. doi: 10.4049/jimmunol.2101154. Epub 2022 Mar 30.

引用本文的文献

1
Transition of cellular senescence to pyroptosis mediates recurrence of small cell lung cancer after chemotherapy.细胞衰老向焦亡的转变介导了小细胞肺癌化疗后的复发。
Sci Adv. 2025 Jul 11;11(28):eadw1553. doi: 10.1126/sciadv.adw1553.
2
The Role of Protein Ubiquitination in the Onset and Progression of Sepsis.蛋白质泛素化在脓毒症发生发展中的作用
Cells. 2025 Jul 2;14(13):1012. doi: 10.3390/cells14131012.
3
Updated insights into the molecular networks for NLRP3 inflammasome activation.对NLRP3炎性小体激活分子网络的最新见解。

本文引用的文献

1
Berberine Directly Targets the NEK7 Protein to Block the NEK7-NLRP3 Interaction and Exert Anti-inflammatory Activity.小檗碱直接靶向 NEK7 蛋白以阻断 NEK7-NLRP3 相互作用并发挥抗炎活性。
J Med Chem. 2021 Jan 14;64(1):768-781. doi: 10.1021/acs.jmedchem.0c01743. Epub 2020 Dec 1.
2
MYD88 L265P elicits mutation-specific ubiquitination to drive NF-κB activation and lymphomagenesis.MYD88 L265P 引发突变特异性泛素化以驱动 NF-κB 激活和淋巴瘤发生。
Blood. 2021 Mar 25;137(12):1615-1627. doi: 10.1182/blood.2020004918.
3
A20: a master regulator of arthritis.
Cell Mol Immunol. 2025 Apr 30. doi: 10.1038/s41423-025-01284-9.
4
A20 attenuates oxidized self-DNA-mediated inflammation in acute kidney injury.A20减轻急性肾损伤中氧化型自身DNA介导的炎症反应。
Signal Transduct Target Ther. 2025 Apr 25;10(1):154. doi: 10.1038/s41392-025-02194-y.
A20:关节炎的主要调节因子。
Arthritis Res Ther. 2020 Sep 21;22(1):220. doi: 10.1186/s13075-020-02281-1.
4
Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors.NEK7 许可的 NLRP3 炎性小体激活的最新进展:机制、在疾病中的作用和相关抑制剂。
J Autoimmun. 2020 Sep;113:102515. doi: 10.1016/j.jaut.2020.102515. Epub 2020 Jul 20.
5
A20 and Cell Death-driven Inflammation.A20 与细胞死亡驱动的炎症
Trends Immunol. 2020 May;41(5):421-435. doi: 10.1016/j.it.2020.03.001. Epub 2020 Mar 30.
6
Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activities.A20 中两个独特的泛素结合基序介导其抗炎和细胞保护活性。
Nat Immunol. 2020 Apr;21(4):381-387. doi: 10.1038/s41590-020-0621-9. Epub 2020 Mar 16.
7
Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis-like disease and inflammation.A20 通过非催化性泛素结合防止银屑病关节炎样疾病和炎症。
Nat Immunol. 2020 Apr;21(4):422-433. doi: 10.1038/s41590-020-0634-4. Epub 2020 Mar 16.
8
An immune-cell signature of bacterial sepsis.细菌脓毒症的免疫细胞特征。
Nat Med. 2020 Mar;26(3):333-340. doi: 10.1038/s41591-020-0752-4. Epub 2020 Feb 17.
9
NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-κB signaling.NEK7 通过 NF-κB 信号与 NLRP3 相互作用,调节炎症性肠病中的细胞焦亡。
Cell Death Dis. 2019 Dec 2;10(12):906. doi: 10.1038/s41419-019-2157-1.
10
PLK4 deubiquitination by Spata2-CYLD suppresses NEK7-mediated NLRP3 inflammasome activation at the centrosome.Spata2-CYLD 通过去泛素化 PLK4 抑制中心体处 NEK7 介导的 NLRP3 炎性小体激活。
EMBO J. 2020 Jan 15;39(2):e102201. doi: 10.15252/embj.2019102201. Epub 2019 Nov 25.